150 related articles for article (PubMed ID: 15497909)
21. Comparative effects of tibolone and conjugated equine estrogens with and without medroxyprogesterone acetate on the reproductive tract of female cynomolgus monkeys.
Cline JM; Register TC; Clarkson TB
Menopause; 2002; 9(4):242-52. PubMed ID: 12082360
[TBL] [Abstract][Full Text] [Related]
22. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
Diaby V; Perreault S; Lachaine J
Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
[TBL] [Abstract][Full Text] [Related]
23. Psychological effects of tibolone and sequential estrogen-progestogen therapy in perimenopausal women.
Inan I; Kelekci S; Yilmaz B
Gynecol Endocrinol; 2005 Feb; 20(2):64-7. PubMed ID: 15823823
[TBL] [Abstract][Full Text] [Related]
24. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables.
Siseles NO; Halperin H; Benencia HJ; Berg G; Pilnik S; Mesch V; Arrighi B; Wikinski RW
Maturitas; 1995 Apr; 21(3):201-10. PubMed ID: 7616869
[TBL] [Abstract][Full Text] [Related]
26. A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.
Thiébaud D; Bigler JM; Renteria S; Pache T; Welti HJ; Landry M; Burckhardt P
Climacteric; 1998 Sep; 1(3):202-10. PubMed ID: 11907945
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
28. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
29. Comparison of tibolone and conjugated equine estrogens effects on carotid artery atherosclerosis of postmenopausal monkeys.
Clarkson TB; Anthony MS; Mikkola TS; St Clair RW
Stroke; 2002 Nov; 33(11):2700-3. PubMed ID: 12411664
[TBL] [Abstract][Full Text] [Related]
30. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
Valdivia I; Campodónico I; Tapia A; Capetillo M; Espinoza A; Lavín P
Fertil Steril; 2004 Mar; 81(3):617-23. PubMed ID: 15037411
[TBL] [Abstract][Full Text] [Related]
31. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
Kiran H; Kiran G
Arch Gynecol Obstet; 2006 Apr; 274(1):9-12. PubMed ID: 16369811
[TBL] [Abstract][Full Text] [Related]
32. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
33. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
34. The effect of hormone therapy on breast density following risk-reducing salpingo-oophorectomy in women with an increased risk for breast and ovarian cancer.
van Barele M; Buis CCM; Brood-van Zanten MMA; van Doorn HLC; Gaarenstroom KN; Heemskerk-Gerritsen BAM; Hooning MJ; de Hullu J; Mourits MJ; Burger CW
Menopause; 2021 Aug; 28(11):1307-1312. PubMed ID: 34374687
[TBL] [Abstract][Full Text] [Related]
35. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results.
Pickar JH; Yeh IT; Wheeler JE; Cunnane MF; Speroff L
Fertil Steril; 2003 Nov; 80(5):1234-40. PubMed ID: 14607581
[TBL] [Abstract][Full Text] [Related]
36. Effects of long-term hormone treatment and of tibolone on monoamines and monoamine metabolites in the brains of ovariectomised, Cynomologous monkeys.
Gibbs RB; Edwards D; Lazar N; Nelson D; Talameh J
J Neuroendocrinol; 2006 Sep; 18(9):643-54. PubMed ID: 16879163
[TBL] [Abstract][Full Text] [Related]
37. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
Pickar JH; Yeh I; Wheeler JE; Cunnane MF; Speroff L
Fertil Steril; 2001 Jul; 76(1):25-31. PubMed ID: 11438315
[TBL] [Abstract][Full Text] [Related]
38. Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine.
Barnes JF; Farish E; Rankin M; Hart DM
Menopause; 2005; 12(1):92-8. PubMed ID: 15668606
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women.
Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC
Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286
[TBL] [Abstract][Full Text] [Related]
40. Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.
Huber J; Palacios S; Berglund L; Hänggi W; Sathanandan SM; Christau S; Helmond F
BJOG; 2002 Aug; 109(8):886-93. PubMed ID: 12197367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
